All Stories

  1. Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy

    Article • Drug Design Development and Therapy, February 2019, Dove Medical Press

    Fernando GOMEZ-PERALTA

  2. Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain

    Article • Diabetic Medicine, July 2018, Wiley

    Fernando GOMEZ-PERALTA, Dr Albert Lecube

  3. Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies

    Article • Endocrinology Diabetes and Metabolism Case Reports, January 2018, Bioscientifica

    Fernando GOMEZ-PERALTA

  4. Incidence, recurrence and cost of hyperglycaemic crises requiring emergency treatment in Andalusia, Spain

    Article • Diabetic Medicine, April 2017, Wiley

    Fernando GOMEZ-PERALTA, Guillermo Umpierrez

  5. Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: A survey research

    Article • Diabetes Research and Clinical Practice, December 2016, Elsevier

    Fernando GOMEZ-PERALTA

  6. Incidence and care‐related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project

    Article • Diabetic Medicine, August 2015, Wiley

    Fernando GOMEZ-PERALTA

  7. ¿Necesitamos nuevos tratamientos para la diabetes tipo 2?

    Article • Endocrinología y Nutrición, June 2014, Elsevier

    Fernando GOMEZ-PERALTA

  8. Do we need new treatments for type 2 diabetes?

    Article • Endocrinología y Nutrición (English Edition), June 2014, Elsevier

    Fernando GOMEZ-PERALTA

  9. Monitorización continua de la glucosa en tiempo real. Indicaciones clínicas probadas

    Article • Avances en Diabetología, November 2011, Elsevier

    Fernando GOMEZ-PERALTA